COMBIGENE AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.56 SEK | +2.30% |
|
-3.78% | +32.34% |
| Mar. 13 | CombiGene's Epilepsy Project CG01 Receives Patent in Two New Countries | CI |
| Feb. 21 | Orphazyme A/S acquired an additional unknown minority stake in CombiGene AB (OM:COMBI). | CI |
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMBIGENE AB | Bio Therapeutic Drugs | +2.30% | -3.78% | +32.34% | -50.90% | -86.91% | 6.35M |  |  | |
- Stock Market
- Equities
- COMBI Stock
- Charts CombiGene AB
- Relative Strength Chart
